About this trial
This study is a randomized, double-blind, placebo-controlled study of N=140 adult men and women with sub-clinical sleep issues. This study to assess the effect of a novel dietary supplement on sleep related outcomes.
Eligibility criteria
Qualifiers
Be male or female
Be aged 35-65.
Body Mass Index: ≥18.5 and ≤29.9 kg/m2
Anyone currently experiencing issues with falling asleep, staying asleep, or waking up during the night
Disqualifiers
Anyone with a diagnosed chronic sleep condition, including but not limited to insomnia, narcolepsy, REM Behavior Disorder, moderate to severe restless leg syndrome (RLS), or sleep apnea.
Women currently undergoing perimenopause or experiencing vasomotor symptoms such as night sweats.
Use of hormone therapy (including estrogen, progesterone, or phytoestrogens) within the last 3 months.
Anyone with diagnosed psychiatric disorders including major depressive disorder with acute symptoms, Bipolar disorder, Generalized anxiety disorder with active symptoms, PTSD with frequent nightmares
Trial design
Treatments tested in this trial
- Novel powdered sleep supplement
- Placebo